3-for-1 split for IBB

BlackRock announced that the Board of Trustees of iShares Trust has authorized a share split for iShares Nasdaq Biotechnology ETF (IBB).

The Board has approved a 3-for-1 split for the fund for shareholders of record as of the close of business on November 28, 2017, payable after the close of trading on November 30, 2017. The 3-for-1 split will lower the share price and increase the number of outstanding shares. The total value of shares outstanding is not affected by the split.

Leave a Reply

Your email address will not be published. Required fields are marked *



You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>